HealthLynked Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
HealthLynked Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2016 to Q3 2024.
  • HealthLynked Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 282M shares, a 6.19% increase year-over-year.
  • HealthLynked Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 263M shares, a 8% increase from 2022.
  • HealthLynked Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 243M shares, a 8.35% increase from 2021.
  • HealthLynked Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 225M shares, a 57.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 282M +16.4M +6.19% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 282M +22M +8.46% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 280M +23.4M +9.08% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 263M +19.5M +8% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 266M +22.2M +9.11% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 260M +21.2M +8.89% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 257M +19.1M +8.03% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 243M +18.8M +8.35% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 243M +11.2M +4.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 239M +10.6M +4.64% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 238M +24.7M +11.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 225M +81.8M +57.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 232M +84.8M +57.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 228M +102M +81.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 213M +98.7M +86.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 143M +43.8M +44.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 147M +44.7M +43.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 126M +27M +27.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 115M +26.1M +29.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 99.1M +20.2M +25.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 103M +23.3M +29.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 98.5M +22.6M +29.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 88.5M +15.6M +21.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 78.8M +9.26M +13.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 79.3M +9.7M +13.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 75.9M +6.46M +9.31% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 72.9M +6.28M +9.42% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 69.6M +9.53M +15.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 69.6M +5.41M +8.43% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 69.4M +14.1M +25.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 66.6M +11.9M +21.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 60M Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 64.2M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 55.3M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 54.7M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.